Oxford, UK – Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has expanded its CytoSure™ product range to include high-throughput genomic DNA labelling kits and sample tracking spike-ins. These new products will further streamline workflow and minimise sample tracking errors when performing array comparative genomic hybridisation (aCGH). […]
London, UK, and Franklin Lakes, NJ – UCL Business (UCLB), a wholly owned subsidiary of University College London (UCL), and BD (Becton, Dickinson and Company), a leading global medical technology company, announced today an agreement aimed at improving the early detection of ovarian and breast cancers to ultimately enable earlier and more effective treatment. “This […]
Oxford, UK – Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, has expanded its CytoSure™ product range to include high-throughput genomic DNA labelling kits and sample tracking spike-ins. These new products will further streamline workflow and minimise sample tracking errors when performing array comparative genomic hybridisation (aCGH). […]
BILLERICA, MA, (February 8, 2011) – Aushon BioSystems, Inc., a leading provider of multiplex immunoassay products and services announced that it has signed a letter of intent to enter into a diagnostic development collaboration with Peking University Cancer Hospital (“PUCH”), Beijing, China. The primary goal for the collaboration is to develop predictive diagnostic markers for […]
Foster City, California – AB SCIEX, a global leader in life science analytical technologies, today announced a collaboration with ARUP Laboratories, a major clinical reference laboratory in the United States, to develop new test methods that clinical research laboratories around the world can adopt to improve hormone analysis. ARUP researchers are using AB SCIEX QTRAP® […]
WASHINGTON – Today, at the American Society for Microbiology Conference on Biodefense and Emerging Diseases, scientists from Abbott Molecular presented data showing the unique power of the company’s Ibis technology to identify and further characterize unknown disease-causing pathogens to help aid in the bioforensic analysis of pandemic outbreaks. In a presentation at the conference, Tim […]
ROCHESTER, N.Y. – Thermal Gradient, a Rochester, NY biotech company, announces a breakthrough in its fast PCR technology for molecular diagnostics. PCR (polymerase chain reaction) is the preferred critical step in virtually all forms of DNA testing. The company’s latest generation of amplification devices has successfully developed and demonstrated the performance of PCR at speeds […]
Washington, D.C. – Abbott (NYSE: ABT) announced today that it has introduced the PLEX-ID™ Biothreat Assay, which is designed to detect and distinguish 17 different biothreat pathogens. This assay enables rapid and accurate detection of potentially dangerous microorganisms that could pose serious threats to human health, food, water and other resources. The PLEX-ID Biothreat Assay […]
Partnership Expected to Expand Molecular Test Offering in Developing Country Markets SUNNYVALE, Calif. and GENEVA, Feb. 3, 2011 — Cepheid (Nasdaq: CPHD) and FIND (Foundation for Innovative New Diagnostics) today announced a new collaboration to accelerate the development of a rapid molecular test for the measurement of human immunodeficiency virus (HIV) viral load. The Xpert® […]
SEATTLE, Wash. – NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the appointment of J. Wayne Cowens, M.D. as Chief Medical Officer. An industry veteran and clinical oncologist, Dr. Cowens will drive the development of the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
